Differentials

Hereditary inclusion body myositis

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Quadriceps more likely to be spared but not always.

May be associated with Paget’s disease and/or frontotemporal dementia.

May have positive family history.

INVESTIGATIONS

Absence of inflammation on muscle biopsy more likely in hereditary inclusion body myositis.[27]

Oculopharyngeal muscular dystrophy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinical features include ptosis, ophthalmoplegia, and dysphagia, occasionally with proximal limb weakness.

May have positive family history.

INVESTIGATIONS

Muscle biopsy shows rimmed vacuoles and tubular filaments with an absence of inflammatory features.[89]

Late-onset distal myopathy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Progressive muscular weakness and atrophy beginning in hands or feet.

INVESTIGATIONS

Muscle biopsy may show rimmed vacuoles and tubulofilamentous inclusions in several types of distal myopathy (e.g., Welander's, Udd's, Markesbery-Griggs, Laing's, distal myopathy), but there is an absence of inflammation.[87]

Amyotrophic lateral sclerosis (motor neuron disease)

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

May mimic inclusion body myositis.

Upper motor neuron signs (not present in idiopathic inflammatory myopathies).

INVESTIGATIONS

Electromyogram shows fasciculation potentials (rare in idiopathic inflammatory myopathies), and neurogenic changes are more apparent.

Muscle biopsy shows neurogenic changes.

Myasthenia gravis

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Weakness more likely to fluctuate, increasing with repeated or sustained exertion.

Involvement of extra-ocular muscles is common and diplopia is a very common symptom.

Spontaneous remissions can occur.

INVESTIGATIONS

Electromyogram (EMG) typically shows abnormal decrement in repetitive nerve stimulation and increased jitter in single-fibre EMG.

Presence of antibodies to acetylcholine receptors or muscle-specific kinase.

Drug-induced myopathy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

History of medication associated with development of myopathy (e.g., statins, penicillamine, laxative abuse).

Withdrawal of implicated drug may reverse the myopathic damage.

As well as being potentially myotoxic, statins can also induce immune-mediated necrotising myopathy (an important IIM subtype).

INVESTIGATIONS

No differentiating tests.

Late-onset Pompe's disease

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

More likely to develop respiratory failure (occurs in approximately one third of patients, may be the presenting symptom).

INVESTIGATIONS

At rest, electromyogram may show myotonic discharges.

Muscle biopsy tissue or cultured skin fibroblasts show a reduction of acid alpha-glucosidase activity.

Secondary metabolic myopathy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Muscle weakness co-exists with systemic manifestations of specific metabolic or endocrine abnormalities, such as hypokalaemia, hypophosphataemia, hypothyroidism, hyperthyroidism, and hyperparathyroidism.

Restoration of muscle strength may occur after correction of the metabolic or endocrine condition.

INVESTIGATIONS

Abnormal blood tests indicating the presence of endocrine or metabolic diagnosis (e.g., low serum potassium or abnormal thyroid function tests).

Chronic inflammatory demyelinating polyneuropathy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Weakness is usually both proximal and distal, and mildly asymmetrical.

Sensory symptoms and signs and diffuse hypo-/areflexia are prominent.

INVESTIGATIONS

Nerve conduction studies show signs of primary demyelination.

Needle electromyogram shows neurogenic pattern and no signs of myopathy.

Serum CK is typically normal.

Scleroderma

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Muscle weakness more likely to be low-grade if present.

INVESTIGATIONS

Mostly mild or absent elevation of serum CK.

Electromyogram shows no or little spontaneous activity.

Muscle biopsy may reveal perimysial fibrosis, scleroderma vasculopathy, and type 2 fibre atrophy with little muscle fibre destruction.[87]

Use of this content is subject to our disclaimer